Healthcare providers able to precisely target, deliver radiation to tumors
Pulaski, VA – The LewisGale Regional Cancer Center at Pulaski is now offering a new technology to treat cancer using highly precise dose rates delivered with greater speed and accuracy anywhere in the body where radiation treatment is indicated.
The new TrueBeam® radiotherapy system is an advanced medical linear accelerator capable of delivering numerous treatment techniques to cancer patients.
Previously, if there were significant changes in a patient’s anatomy during the course of treatment or if a tumor was near a critical body structure, those challenges made it difficult for clinicians to target and deliver radiation treatment. This new system addresses those technical challenges – particularly for cancers of the head and neck, breast, lung, and prostate, by continuously monitoring tumor movement and helping clinicians deliver radiation only when the tumor is in the right place.
“This new medical technology will continue to position our Regional Cancer Center at Pulaski at the forefront in the fight against cancer today, and well into the future,” said Sean Pressman, CEO of LewisGale Hospital Pulaski. “Patients will have greater access to the latest cancer-fighting treatments where it’s most convenient for them and their families – close to home.”
TrueBeam supports a wide variety of imaging and treatment delivery techniques, and its combination of 2D, 3D, and 4D imaging allows flexible and customizable images that are needed to develop individualized treatment plans specific to each patient.
This new cancer-fighting medical technology joins a long list of additions over the last several years to the Cancer Center’s treatment techniques including Stereotactic Body Radiation Therapy and High Dose Rate (HDR) Brachytherapy. These additions are part of the reason LewisGale Hospital Pulaski is the only Cancer Center in Southwest Virginia accredited by both the American College of Surgeons Commission on Cancer and the American College of Radiology, and is ranked among the top five percent of all HCA Cancer Centers nationwide.